Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering

NCT04081584 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2021-08-11

No results posted yet for this study

Summary

This study is being conducted to study light scattering properties of maternal-fetal tissue.

Conditions

  • Fetal Distress

Interventions

DEVICE

ISS Device

The ISS Device (commercial and prototype) is used to measure tissue light scattering.

Sponsors & Collaborators

  • Raydiant Oximetry, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2021-05-20
Completion
2021-06-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04081584 on ClinicalTrials.gov